The global voiding cystourethrogram market size was valued at around US$ 1.37 Billion in 2021 and is projected to grow at a healthy CAGR of around 7.5% between 2022 and 2032, surpassing a valuation of approximately US$ 2.6 Billion by 2032. Growth in the market is driven by the rising prevalence of urinary disorders such as urinary tract incontinence and urinary tract infections around the world.
| Report Attribute | Details |
| Voiding Cystourethrogram Market Estimated Base Year Value (2021) | US$ 1.37 Billion |
| Voiding Cystourethrogram Market Anticipated Forecast Value (2032) | US$ 2.6 Billion |
| Voiding Cystourethrogram Market Projected Growth Rate (2022-2032) | 7.5% CAGR |
Voiding Cystourethrogram is a commonly performed technique which uses real-time X-ray and a contrast material for assessing or visualizing a person’s urethra and urinary bladder while the person urinates. It has become an essential procedure for the diagnosis of various urinary disorders such as urinary tract incontinence, vesicoureteral reflux and urinary tract infections.
During voiding cystourethrogram, catheterization is done initially to fill the person's bladder with a radiocontrast agent (mostly diatrizoic acid). After that, the medical professional or radiologist analyzes the contrast agent moving into the urinary bladder and observes the patient’s anatomy under fluoroscopy. The result shown during the voiding cystourethrogram indicates the medical condition and determines the kind of treatment required by the patient.
Growing awareness among people regarding urological disorders, their diagnosis and treatment is playing a key role in fueling the adoption of voiding cystourethrogram procedure. Most of the patients (typically children) diagnosed with UTIs (Urinary Tract Infections) are advised by medical professionals to go through a voiding cystourethrogram procedure for determining the risks associated and subsequent infections causing potential kidney damage.
Similarly, rapid technological advancements in voiding cystourethrogram products along with an increase in the number of hospitals, radiology centers and speciality clinics expected to boost the market growth during the assessment period.
The swift growth of voiding cystourethrogram market is attributable to the rising prevalence of urinary tract infections, growing demand for minimally invasive procedures, technological advancements in voiding cystourethrogram devices, and increasing health awareness among people worldwide.
Voiding cystourethrogram has emerged as an ideal minimally invasive technique for the diagnosis of various urinary disorders. It is being increasingly used, particularly in children to pinpoint anything abnormal about the urethra and the bladder.
The increasing incidence of urinary tract infections is perhaps one of the major factors boosting the growth of the voiding cystourethrogram market and the trend is likely to continue during the forecast period. According to the American Urological Association (AUA), an estimated 150 million UTIs occur yearly worldwide.
Subsequently, growing health awareness among people coupled with the rising need for early detection of urinary disorders is encouraging people to opt for minimally invasive procedures like voiding cystourethrogram. This not only helps the medical professionals to initiate a proper treatment but also eliminates the spread of infection to vital organs.
In addition to this, rising imaging procedures worldwide along with advancements in voiding cystourethrogram products and the introduction of favourable reimbursement policies for voiding cystourethrography is likely to assist market growth during the assessment period.
Despite positive growth projections, the global cystourethrogram market is facing various challenges that are limiting its growth to a large extent. Some of these challenges are the side effects such as hot flashes, nausea vomiting, heart attack, breathing problem and low blood pressure associated with voiding cystourethrogram and the high procedural cost of voiding cystourethrogram.
As per FMI, North America is expected to retain its top position in the global voiding cystourethrogram market, owing to the rising prevalence of urological disorders, increasing geriatric population, the rapid expansion of the healthcare sector, growing consumer preference for minimally invasive procedures, and heavy presence of leading market players across countries like the United States and Canada.
The voiding cystourethrogram market is especially flourishing across countries like the United States and Canada due to increasing health expenditure, a rise in the number of diagnostic centers, the presence of favorable reimbursement policies, and a growing number of people for regular check-ups.
According to Future Market Insights, Europe is expected to remain the second leading market for voiding cystourethrogram during the forecast period. Growth is attributable to the rising patient pool, high awareness levels among people, increasing government support, and the presence of leading market players.
Countries such as the U.K., Poland, Germany, and France are all generating high demand for voiding cystourethrograms, as these regions are witnessing a rapid upsurge in the cases of urinary tract infections and other urological disorders.
Some of the key participants present in the global voiding cystourethrogram market include Merck & Co., Inc., Medtronic, General Electric Company, Siemens AG, Koninklijke Philips N.V., Block Imaging International, Inc., Carestream Health, Inc. BMI Biomedical International s.r.l., Hitachi Medical Systems, and FUJIFILM Holdings Corporation.
Most of these market players are continuously focusing on introducing novel products to enable end users to get a better assessment of urinary disorders. Moreover, they are indulging in growth strategies such as collaborations, partnerships, and acquisitions to expand their global footprint.
| Report Attribute | Details |
| Growth Rate | CAGR of 7.5% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
By Product Type:
By Age Group:
By End Use:
By Region:
FMI projects the global voiding cystourethrogram market to expand at around 7.5% CAGR throughout the forecast period from 2022 and 2032.
North America is expected to remain the most dominant market for voiding cystourethrogram during the assessment period.
Merck & Co., Inc., Medtronic, General Electric Company, Siemens AG, and Koninklijke Philips N.V. are some prominent voiding cystourethrogram market players.
Voiding Cystourethrogram Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
